Company Filing History:
2 out of 2 
1 out of 95 
1 out of 7 Years Active: 2014-2024
Title: Mary Rea: Innovator in the Treatment of C. difficile
Introduction
Mary Rea is a prominent inventor based in Fermoy, Ireland, known for her significant contributions to the field of medical treatments. With a total of three patents to her name, she has focused her research on innovative methods for combating infections, particularly those caused by C. difficile.
Latest Patents
Mary Rea's latest patents include groundbreaking methods and compositions for the treatment of C. difficile. These patents disclose compositions and methods aimed at preventing, ameliorating, or treating infections. They also focus on reducing the severity of risk factors, signs, or symptoms associated with these infections. The technology involves administering an effective amount of a composition comprising specific strains of bacteria identified as ART24, ART4, and ART12 to subjects suffering from or at risk for infections.
Career Highlights
Throughout her career, Mary has made notable strides in the medical field. She has worked with Artugen Therapeutics Ltd., where her research has contributed to the development of innovative therapeutic solutions. Additionally, her association with University College Cork has further solidified her reputation as a leading inventor in her area of expertise.
Collaborations
Mary Rea has collaborated with esteemed colleagues, including Colin Hill and Paul Ross. Their combined efforts have advanced the research and development of effective treatments for bacterial infections.
Conclusion
Mary Rea's work exemplifies the impact of innovation in the medical field, particularly in the treatment of C. difficile infections. Her patents and collaborations highlight her commitment to improving health outcomes through scientific research and innovation.